Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 18, 2022 10:00 AM - Nov 18, 2022 11:30 PM

(US Eastern Standard Time)

Harnessing the Power of Structured Content in Life Sciences: Practicalities, Challenges, and Opportunities in the Evolving Technology Landscape

Presenters

Katherine  Novak, MS

Katherine Novak, MS

Principal Product Manager, Accumulus Synergy, United States

Katherine Novak provides experience as a Business Analyst across the full drug product lifecycle, including Clinical Research, Regulatory Operations, Regulatory Information Management, Pharmacovigilance, and large-scale Manufacturing. She obtained her MS degree from Georgetown University in Clinical and Translational Research, where she focused on large-scale meta-analyses as a basis for clinical trials. With over four years of experience in the life science industry, Katherine supports clients in system implementation, process development, and data quality. Her passion is in data standard harmonization, specifically Regulatory data and optimization for Regulatory decision-making.

Nicholas  Rattenni

Nicholas Rattenni

Senior Advisory Consultant, NNIT, United States

Nicholas Rattenni is currently a Senior Advisory Consultant at NNIT within the US Life Sciences Advisory and Consulting team. Nick has worked in life sciences, focusing primarily on global regulatory initiatives and labeling including data standards and business development

Sarah  Powell, RAC

Sarah Powell, RAC

President, Powell Regulatory Services, United States

Ms. Powell is the President of Powell Regulatory Services. Sarah has 30+ years of experience in pharmaceutical and related regulated industries (Clinical, Quality Control, Regulatory Affairs and Regulatory Operations). In the past 23 years as a consultant, she has assisted clients with projects related to regulatory process improvements, standards development, defining filing strategies and writing/review of submission content. She has extensive experience with projects related to design and implementation of regulatory solutions including document management, submission planning, publishing, and registration management. Sarah is a past executive at Chiron, First Consulting Group and Liquent, and PAREXEL

Mitzi  Allred, PhD

Mitzi Allred, PhD

Director, Clinical Operations, Merck & Co., Inc, United States

Mitzi Allred is a Director at MSD where her focus is on Structured Content Management. She has over 20 years of experience in the biopharmaceutical industry in Regulatory & Clinical Operations. Mitzi uses process improvement through information design and structured content reuse to leverage time. quality and efficiency for content within documents . Over the last fifteen years, she has led improvements in electronic documents, structured content management reuse implementations. Mitzi participates in the TransCelerate Clinical Content & Reuse workstream and ICH M11 Working group. Additionally, Mitzi has PhD in engineering and 15 years of experience in Aerospace.

John Henry April, MA

John Henry April, MA

Senior Director, Adaptive Content Strategy, Global Scientific Communications, Eli Lilly and Company, United States

Twenty-five years of drug development experience focused on medical writing. Highlights include developing content reuse and generative AI strategies for Lilly, retooling Lilly's medical writing staff to structure its content, leading a medical writing start-up in India, designing a Question Based Review (QBR) document development strategy, expanding medical writing's influence in clinical pharmacology, and playing key roles in developing integrated outsourcing strategies.

Todd  Georgieff, MBA, RPh

Todd Georgieff, MBA, RPh

Principal, futurpositif - Digital Clinical Trials Consulting, Canada

Todd has been working in Drug Development for more than 30 years. He has extensive experience in clinical operations and also participated in and led many large-scale change and process improvement initiatives. Todd is currently Product Owner for implementation of a new Protocol authoring. Prior to his current role, he was Roche’s Program Lead for TransCelerate.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.